4//SEC Filing
MOLINA ARTURO MD 4
Accession 0001104659-25-024063
CIK 0001377121other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:21 PM ET
Size
13.0 KB
Accession
0001104659-25-024063
Insider Transaction Report
Form 4
MOLINA ARTURO MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-13$23.42/sh+28,437$665,995→ 112,329 total - Exercise/Conversion
Common Stock
2025-03-13$38.98/sh+2,077$80,961→ 114,406 total - Sale
Common Stock
2025-03-13$55.74/sh−30,514$1,700,850→ 83,892 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-13−28,437→ 69,063 totalExercise: $23.42Exp: 2034-01-02→ Common Stock (28,437 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-03-13−2,077→ 47,785 totalExercise: $38.98Exp: 2035-01-02→ Common Stock (2,077 underlying)
Footnotes (3)
- [F1]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.245 to $56.06. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F2]The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
- [F3]The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001398940
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:21 PM ET
- Size
- 13.0 KB